deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT01501487

MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I (MINT)

Sponsor: AdventHealth

Conditions Breast Cancer
Interventions Dose Dense AC or FEC100 followed by paclitaxel or docetaxel chemotherapy Dose dense AC followed by T + trastuzumab Dose dense AC followed by T + trastuzumab + pertuzumab PTH followed by dose dense AC of FEC T + trastuzumab followed by CEF + trastuzumab TAC chemotherapy TC chemotherapy TCH chemotherapy
Updated 8 times since 2017 Last updated: Jun 26, 2018 Started: Oct 31, 2011 Primary completion: Feb 29, 2016 Completion: Jun 30, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01501487, this PHASE4 trial focuses on Breast Cancer and remains completed. Sponsored by AdventHealth, it has been updated 8 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotActive Not Recruiting~Jul 2018 – ~May 2020 · 22 months · monthly snapshotCompleted~May 2020 – ~Jan 2021 · 8 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. May 2020 — Jan 2021 [monthly]

    Completed PHASE4

▶ Show 3 earlier versions

  1. Jul 2018 — May 2020 [monthly]

    Completed PHASE4

    Status: Active Not Recruiting → Completed

  2. Jun 2018 — Jul 2018 [monthly]

    Active Not Recruiting PHASE4

  3. Jan 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE4

    First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AdventHealth
  • Agendia
  • Morton Plant Mease Health Care
  • Ohio State University Comprehensive Cancer Center
  • Plano Cancer Center
  • University of Miami
  • University of Oklahoma
  • University of South Alabama
  • University of South Florida
Data source: Agendia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations